ArticleMolecular oncology2023

Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts.

Timm M Reissig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.